FindTrial
Sign In

Elobixibat

DRUG5 trials

Sponsors

Manabe Noriaki, Tsujita Kenichi, International university health and welfare Narita hospital, Ferring Pharmaceuticals, Albireo

Conditions

Chronic Idiopathic ConstipationChronic constipationHeart failure complicated with chronic constipation chronic constipationNAFLDNASHchronic constipation chronic constipation

Phase 2

Elobixibat Colonic Motor Function Study
WithdrawnNCT02392546
Ferring PharmaceuticalsChronic Idiopathic Constipation
Start: 2015-04-30End: 2016-04-30Updated: 2015-06-03
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
CompletedNCT04006145
AlbireoNAFLD, NASH
Start: 2019-06-06End: 2020-07-15Updated: 2026-02-05

Unknown Phase

Effects of Elobixibat in patients with heart failure complicated with chronic constipation
Active, not recruitingJPRN-jRCTs071190055
Tsujita KenichiHeart failure complicated with chronic constipation chronic constipation
Start: 2020-08-17Target: 50Updated: 2026-06-29
Effects of Elobixibat on rectal visceral perception in constipated patients over 60 years of age
Active, not recruitingJPRN-jRCTs061200030
Manabe Noriakichronic constipation chronic constipation
Start: 2021-02-18Target: 30Updated: 2026-06-29
A Multicenter, Single-group, Open-label, Before-and-after Study Confirming Recovery of Defecation Desire by Administration of Elobixibat in Patients With Chronic Constipation
Active, not recruitingJPRN-UMIN000050080
International university health and welfare Narita hospitalChronic constipation
Start: 2023-02-01Target: 40Updated: 2026-06-29

Related Papers

Elobixibat Improves Stool/Gas Distribution and Fecal Bile Acids in Older Adults With Chronic Constipation
JGH Open2025-08-012 citations
Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study
BMJ Open Gastroenterology2023-11-016 citations